qhaxonqu

Property	Value
?:abstract	BACKGROUND: The COVID-19 pandemic has led to many countries implementing lockdown procedures, resulting in the suspension of laboratory research. With lockdown measures now easing in some areas, many laboratories are preparing to reopen. This is particularly challenging for clinical research laboratories due to the dual risk of patient samples carrying the virus that causes COVID-19, SARS-CoV-2, and the risk to patients being exposed to research staff during clinical sampling. To date, no confirmed transmission of the virus has been confirmed within a laboratory setting; however, operating processes and procedures should be adapted to ensure safe working of samples of positive, negative, or unknown COVID-19 status. OBJECTIVE: In this paper, we propose a framework for reopening a clinical research laboratory and resuming operations with the aim to maximize research capacity while minimizing the risk to research participants and staff. METHODS: This framework was developed by consensus among experienced laboratory staff who have prepared to reopen a clinical research laboratory. RESULTS: Multiple aspects need to be considered to reopen a clinical laboratory. We describe our process to stratify projects by risk, including assessment of donor risk and COVID-19 clinical status, the COVID-19 status of the specific sample type, and how to safely process each sample type. We describe methods to prepare the laboratory for safe working including maintaining social distancing through signage, one-way systems and access arrangements for staff and patients, limiting staff numbers on site and encouraging home working for all nonlaboratory tasks including data analysis and writing. Shared equipment usage was made safe by adapting booking systems to allow for the deployment of cleaning protocols. All risk assessments and standard operating procedures were rewritten and approved by local committees, and staff training was initiated to ensure compliance. CONCLUSIONS: Laboratories can adopt and adapt this framework to expedite reopening a clinical laboratory during the current COVID-19 pandemic while mitigating the risk to research participants and staff.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/qhaxonqu_hasAnnotation_C0042776> <https://research.tib.eu/covid-19/entity/qhaxonqu_hasAnnotation_C2937289> <https://research.tib.eu/covid-19/entity/qhaxonqu_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Walker%2C_Eloise_M%3B_Jasper%2C_Alice_E%3B_Davis%2C_Lauren%3B_Yip%2C_Kay_Por%3B_Faniyi%2C_Aduragbemi_A%3B_Hughes%2C_Michael_J%3B_Crisford%2C_Helena_A%3B_Spittle%2C_Daniella_A%3B_Sapey%2C_Elizabeth%3B_Belchamber%2C_Kylie_B_R%3B_Scott%2C_Aaron>
?:doi	10.2196/22570
?:doi	<https://research.tib.eu/covid-19/entity/10.2196/22570>
?:journal	JMIR_Res_Protoc
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/89c4158909964f1165626a9a7eb778bac5f3b09e.json
?:pmc_json_files	document_parses/pmc_json/PMC7721628.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7721628>
?:pmid	<https://research.tib.eu/covid-19/entity/33146625.0>
?:pmid	33146625.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/89c4158909964f1165626a9a7eb778bac5f3b09e>
?:source	Medline; PMC
?:title	Mitigating Health Risks to Reopen a Clinical Research Laboratory During the COVID-19 Pandemic: A Framework
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-04

Property

Value

?:abstract

BACKGROUND: The COVID-19 pandemic has led to many countries implementing lockdown procedures, resulting in the suspension of laboratory research. With lockdown measures now easing in some areas, many laboratories are preparing to reopen. This is particularly challenging for clinical research laboratories due to the dual risk of patient samples carrying the virus that causes COVID-19, SARS-CoV-2, and the risk to patients being exposed to research staff during clinical sampling. To date, no confirmed transmission of the virus has been confirmed within a laboratory setting; however, operating processes and procedures should be adapted to ensure safe working of samples of positive, negative, or unknown COVID-19 status. OBJECTIVE: In this paper, we propose a framework for reopening a clinical research laboratory and resuming operations with the aim to maximize research capacity while minimizing the risk to research participants and staff. METHODS: This framework was developed by consensus among experienced laboratory staff who have prepared to reopen a clinical research laboratory. RESULTS: Multiple aspects need to be considered to reopen a clinical laboratory. We describe our process to stratify projects by risk, including assessment of donor risk and COVID-19 clinical status, the COVID-19 status of the specific sample type, and how to safely process each sample type. We describe methods to prepare the laboratory for safe working including maintaining social distancing through signage, one-way systems and access arrangements for staff and patients, limiting staff numbers on site and encouraging home working for all nonlaboratory tasks including data analysis and writing. Shared equipment usage was made safe by adapting booking systems to allow for the deployment of cleaning protocols. All risk assessments and standard operating procedures were rewritten and approved by local committees, and staff training was initiated to ensure compliance. CONCLUSIONS: Laboratories can adopt and adapt this framework to expedite reopening a clinical laboratory during the current COVID-19 pandemic while mitigating the risk to research participants and staff.

is ?:annotates of